Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
Disease Modifying Therapies for Multiple Sclerosis
Jonathan L. Carter
Neurology
Research output
:
Contribution to journal
›
Article
›
peer-review
4
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Disease Modifying Therapies for Multiple Sclerosis'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Multiple Sclerosis
100%
Interferon beta-1b
38%
Adrenal Cortex Hormones
20%
Therapeutics
18%
Cladribine
18%
Chronic Progressive Multiple Sclerosis
17%
Magnetic Resonance Imaging
16%
Interferon-beta
14%
Azathioprine
13%
North America
13%
United States Food and Drug Administration
12%
Methotrexate
12%
Cyclophosphamide
11%
Interferons
11%
Immunosuppression
11%
Immunotherapy
11%
Immunosuppressive Agents
10%
Disease Progression
10%
Placebos
8%
Health Care Outcome Assessment
8%
Clinical Trials
8%
Recurrence
7%
Pharmaceutical Preparations
5%